Could Home Monitoring parameters provide information about the impact of the pandemic period on CIED patients? A comparison between 2019 and 2020

Bontempi, Luca; Aboelhassan, Mohamed; Cerini, Manuel; Salghetti, Francesca; Fabbricatore, Davide; Maiolo, Vincenzo; Freda, Laura; Giacopelli, Daniele; Curnis, Antonio

doi:10.2459/jcm.0000000000001193

Cited by 6 publications

(6 citation statements)

References 6 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results are in keeping with that reported by other Italian authors who compared the outcome of a series of 124 remotely monitored ICD patients in 2019 versus 2020. They observed a lower amount of physical activity in 2020 as a result of the lock down but no significant differences in other end points including the incidence of arrhythmias 15 …”

Section: Discussionmentioning

confidence: 94%

“…They observed a lower amount of physical activity in 2020 as a result of the lock down but no significant differences in other end-points including the incidence of arrhythmias. 15 A previous study based on a 100-day period found that measures of social isolation imposed by authorities in 2020 resulted in a lower proportion of ICD patients experiencing ventricular arrhythmias compared to 2019, highlighting the potential role of real-life stressors in ventricular arrhythmia burden. 16 In 2020, the Italian government enforced different degree of restrictions.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy

Zorzi

Mattesi²,

Frigo

et al. 2022

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

Background The 2020 severe acute respiratory syndrome coronavirus 2 outbreak entailed reduced availability of traditional (in-office) cardiology consultations. Remote monitoring is an alternative way of caring that may potentially mitigate the negative effects of the epidemic to the care of cardiovascular diseases. We evaluated the outcome of implantable cardioverter defibrillator (ICD) carriers followed up remotely in 2020 (epidemic period) versus 2019 (control). Methods We included all patients with an ICD who remained remotely monitored from the beginning to the end of each year. The combined end point included: new-onset atrial fibrillation; sustained ventricular tachycardia >170 bpm without ICD intervention; appropriate ICD intervention (either shock or antitachycardia pacing); any-cause death. Multiple events in the same patients were counted separately if occurring ≥48 h apart. Results In 2020, 52 end points occurred in 37 of 366 (10%) ICD carriers [0.14/patient (95% confidence interval [CI] = 0.11–0.19)] versus 43 end points in 32 of 325 (10%) ICD carriers in 2019 [0.13/patient (95% CI = 0.10–0.18) P = 0.75]. There was no difference between the distribution of any individual end point in 2020 versus 2019 although a nonsignificant mortality increase was observed (from 2.8% to 4.6%, P = 0.19). The lowest weekly event rate occurred during the national lock down in spring 2020 but a similar trend occurred also in 2019 suggesting that the effect may not be linked to social distancing measures. Conclusions We did not observe an increase in a combined end point including arrhythmic events and mortality in ICD carriers who were remotely monitored in 2020, compared to 2019, despite the negative impact of the coronavirus disease 2019 outbreak on the healthcare system.

show abstract

Section: Discussionmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 97%

Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy

Zorzi

Mattesi²,

Frigo

et al. 2022

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

show abstract

“…After the initial screening, the full texts of the remaining 43 documents were reviewed. Three opinion articles [23][24][25], four review articles [6,[26][27][28], two case reports or case series [29,30], one long COVID study [31], five studies that did not report HRV [32][33][34][35][36], eleven studies without a control group [37][38][39][40][41][42][43][44][45][46][47], and one study that used data from the journal article which was the same as the data presented in the conference abstract [48] were excluded. The inter-rater agreement rate among the researchers in the full texts review was 97.67% (42/43).…”

Section: Study Selectionmentioning

confidence: 99%

The Impact of SARS-CoV-2 Infection on Heart Rate Variability: A Systematic Review of Observational Studies with Control Groups

Kwon

2023

IJERPH

View full text Add to dashboard Cite

Autonomic nervous system (ANS) dysfunction can arise after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and heart rate variability (HRV) tests can assess its integrity. This review investigated the relationship between the impact of SARS-CoV-2 infection on HRV parameters. Comprehensive searches were conducted in four electronic databases. Observational studies with a control group reporting the direct impact of SARS-CoV-2 infection on the HRV parameters in July 2022 were included. A total of 17 observational studies were included in this review. The square root of the mean squared differences of successive NN intervals (RMSSD) was the most frequently investigated. Some studies found that decreases in RMSSD and high frequency (HF) power were associated with SARS-CoV-2 infection or the poor prognosis of COVID-19. Also, decreases in RMSSD and increases in the normalized unit of HF power were related to death in critically ill COVID-19 patients. The findings showed that SARS-CoV-2 infection, and the severity and prognosis of COVID-19, are likely to be reflected in some HRV-related parameters. However, the considerable heterogeneity of the included studies was highlighted. The methodological quality of the included observational studies was not optimal. The findings suggest rigorous and accurate measurements of HRV parameters are highly needed on this topic.

show abstract

“… 10–12 The measures of physical distancing implemented in many countries during the COVID-19 created a broader and urgent need for wider adoption of digital solutions, and among them, RM. 2 , 13 , 14 As a consequence, there was an acceleration in the development of telemedicine and the use of RM in order to follow cardiac patients at distance. 10 , 11 , 15–17 …”

Section: Rm and Covid-19 Pandemicmentioning

confidence: 99%

Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe

et al. 2022

View full text Add to dashboard Cite

Remote monitoring (RM) of cardiac implantable electrical devices (CIEDs) is currently proposed as a standard of care for CIEDs follow-up, as recommended by major cardiology societies worldwide. By detecting a series of relevant device and patient-related parameters, RM is a valuable option for early detection of CIEDs' technical issues, as well as changes in parameters related to cardio-respiratory functions. Moreover, RM may allow longer spacing between in-office follow-ups and better organization of in-hospital resources. Despite these potential advantages, resulting in improved patient safety, we are still far from a widespread diffusion of RM across Europe. Reimbursement policies across Europe still show an important heterogeneity and have been considered as an important barrier to full implementation of RM as a standard for the follow-up of all the patients with pacemakers, defibrillators, devices for cardiac resynchronization, or implantable loop recorders. Indeed, in many countries, there are still inertia and unresponsiveness to the request for widespread implementation of RM for CIEDs, although an improvement was found in some countries as compared to years ago, related to the provision of some form of reimbursement. As a matter of fact, the COVID-19 pandemic has promoted an increased use of digital health for connecting physicians to patients, even if digital literacy may be a limit for the widespread implementation of telemedicine. CIEDs have the advantage of making possible RM with an already defined organization and reliable systems for data transmissions that can be easily implemented as a standard of care for present and future cardiology practice.

show abstract

Could Home Monitoring parameters provide information about the impact of the pandemic period on CIED patients? A comparison between 2019 and 2020

Cited by 6 publications

References 6 publications

Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy

Impact of coronavirus disease 19 outbreak on arrhythmic events and mortality among implantable cardioverter defibrillator patients followed up by remote monitoring: a single center study from the Veneto region of Italy

The Impact of SARS-CoV-2 Infection on Heart Rate Variability: A Systematic Review of Observational Studies with Control Groups

Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe

Contact Info

Product

Resources

About